|
Myeloid Neoplasia
Citations 91-100 of 176 total displayed.
|
Past content
(since Jan 2009):
|
Chemosensitization of acute myeloid leukemia (AML) following mobilization by the CXCR4 antagonist AMD3100
- Bruno Nervi, Pablo Ramirez, Michael P. Rettig, Geoffrey L. Uy, Matthew S. Holt, Julie K. Ritchey, Julie L. Prior, David Piwnica-Worms, Gary Bridger, Timothy J. Ley, and John F. DiPersio
Blood 2009; 113: 6206-6214.
[Abstract]
[Full text]
[PDF]
Targeting the leukemia microenvironment by CXCR4 inhibition overcomes resistance to kinase inhibitors and chemotherapy in AML
- Zhihong Zeng, Yue Xi Shi, Ismael J. Samudio, Rui-Yu Wang, Xiaoyang Ling, Olga Frolova, Mark Levis, Joshua B. Rubin, Robert R. Negrin, Elihu H. Estey, Sergej Konoplev, Michael Andreeff, and Marina Konopleva
Blood 2009; 113: 6215-6224.
[Abstract]
[Full text]
[PDF]
Systemic mastocytosis in 342 consecutive adults: survival studies and prognostic factors
- Ken-Hong Lim, Ayalew Tefferi, Terra L. Lasho, Christy Finke, Mrinal Patnaik, Joseph H. Butterfield, Rebecca F. McClure, Chin-Yang Li, and Animesh Pardanani
Blood 2009; 113: 5727-5736.
[Abstract]
[Full text]
[PDF]
Pivotal role of mast cells in pruritogenesis in patients with myeloproliferative disorders
- Takefumi Ishii, Jiapeng Wang, Wei Zhang, John Mascarenhas, Ronald Hoffman, Ying Dai, Nathaniel Wisch, and Mingjiang Xu
Blood 2009; 113: 5942-5950.
[Abstract]
[Full text]
[PDF]
Clinical relevance of Wilms tumor 1 gene mutations in childhood acute myeloid leukemia
- Iris H. I. M. Hollink, Marry M. van den Heuvel-Eibrink, Martin Zimmermann, Brian V. Balgobind, Susan T. C. J. M. Arentsen-Peters, Marielle Alders, Andre Willasch, Gertjan J. L. Kaspers, Jan Trka, Andre Baruchel, Siebold S. N. de Graaf, Ursula Creutzig, Rob Pieters, Dirk Reinhardt, and C. Michel Zwaan
Blood 2009; 113: 5951-5960.
[Abstract]
[Full text]
[PDF]
Prevalence, determinants, and outcomes of nonadherence to imatinib therapy in patients with chronic myeloid leukemia: the ADAGIO study
- Lucien Noens, Marie-Anne van Lierde, Robrecht De Bock, Gregor Verhoef, Pierre Zachée, Zwi Berneman, Philippe Martiat, Philippe Mineur, Koen Van Eygen, Karen MacDonald, Sabina De Geest, Tara Albrecht, and Ivo Abraham
Blood 2009; 113: 5401-5411.
[Abstract]
[Full text]
[PDF]
Genome-wide association study to identify novel loci associated with therapy-related myeloid leukemia susceptibility
- Jeffrey A. Knight, Andrew D. Skol, Abhijit Shinde, Darcie Hastings, Richard A. Walgren, Jin Shao, Thelma R. Tennant, Mekhala Banerjee, James M. Allan, Michelle M. Le Beau, Richard A. Larson, Timothy A. Graubert, Nancy J. Cox, and Kenan Onel
Blood 2009; 113: 5575-5582.
[Abstract]
[Full text]
[PDF]
High frequency of RUNX1 biallelic alteration in acute myeloid leukemia secondary to familial platelet disorder
- Claude Preudhomme, Aline Renneville, Violaine Bourdon, Nathalie Philippe, Catherine Roche-Lestienne, Nicolas Boissel, Nathalie Dhedin, Jean-Marie André, Pascale Cornillet-Lefebvre, André Baruchel, Marie-Joelle Mozziconacci, and Hagay Sobol
Blood 2009; 113: 5583-5587.
[Abstract]
[Full text]
[PDF]
JAK2V617F mutation for the early diagnosis of Ph– myeloproliferative neoplasms in patients with venous thromboembolism: a meta-analysis
- Francesco Dentali, Alessandro Squizzato, Lorenza Brivio, Lorena Appio, Leonardo Campiotti, Mark Crowther, Anna Maria Grandi, and Walter Ageno
Blood 2009; 113: 5617-5623.
[Abstract]
[Full text]
[PDF]
Failure to achieve a complete hematologic response at the time of a major cytogenetic response with second-generation tyrosine kinase inhibitors is associated with a poor prognosis among patients with chronic myeloid leukemia in accelerated or blast phase
- Carmen Fava, Hagop M. Kantarjian, Elias Jabbour, Susan O'Brien, Nitin Jain, Mary Beth Rios, Guillermo Garcia-Manero, Farhad Ravandi, Srdan Verstovsek, Gautam Borthakur, Jianqin Shan, and Jorge Cortes
Blood 2009; 113: 5058-5063.
[Abstract]
[Full text]
[PDF]
|
|
